ArticleOphthalmology science2026
Improving Fairness and Mitigating Bias in Multicenter Electronic Health Records Models to Predict Glaucoma Outcomes.
Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Purpose: To evaluate the effectiveness and generalizability of bias mitigation methods in glaucoma progression prediction models across a multicenter electronic health records (EHRs) repository and to propose a novel evaluation metric that balances performance and fairness in clinical artificial intelligence (AI). Design: A cohort study. Participants: A total of 50 656 glaucoma patients drawn from seven participating institutions in the SOURCE consortium, a harmonized EHR repository spanning ophthalmology departments in the United States. Methods: We trained five model architectures (e.g., XGBoost, neural networks, and transformers) to predict progression to surgery. Each model was evaluated with and without five bias-mitigation methods across preprocessing, inprocessing, and postprocessing. Performance and fairness were assessed on 1 internal and 2 external test sets. We introduced FairOdds-AUC, a composite metric that adjusts area under the receiver operating curve (AUROC) by equalized odds gaps across sex and race/ethnicity. The FairOdds-AUC metric was implemented in Python and is available as an open-source package for reproducibility and future use. Main Outcome Measures: Area under the receiver operating curve, equalized odds for sex and race/ethnicity, and FairOdds-AUC. Results: Inprocessing methods, particularly inverse propensity weighting (IPW) and the adversarial fairness classifier, achieved more favorable fairness-performance tradeoffs than baseline and other mitigation approaches across all evaluation sets. For example, on the internal test set, IPW improved FairOdds-AUC from 0.562 (95% confidence interval 0.540, 0.581) to 0.600 (0.575, 0.629) for the transformer model and from 0.556 (0.534, 0.577) to 0.5922 (0.53, 0.61919) for a fully connected network, while maintaining essentially the same discrimination. Adversarial fairness classifier achieved the highest FairOdds-AUC in several settings (up to 0.613 [0.595, 0.629] for the deep learning fully connected network) with substantial reductions in equalized odds difference for sex. Postprocessing and preprocessing bias mitigation strategies yielded more variable FairOdds-AUC changes (-0.009 to +0.021) and showed weaker generalizability across external sites. FairOdds-AUC consistently reflected the balance between AUROC and equalized odds, with the optimal mitigation strategy depending on fairness-utility priorities. Conclusions: Across a large, diverse glaucoma cohort, inprocessing bias methods provided the most consistent performance across evaluation sites in promoting fairness. FairOdds-AUC offers a flexible, interpretable way to evaluate clinical AI where fairness matters. Our findings support the recommendation to incorporate fairness evaluations and fairness-aware model training for future ophthalmic AI applications. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.